Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Sirolimus for Autoimmune Disease of Blood Cells: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus for Autoimmune Disease of Blood Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00392951).
- Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02357342).
- SIRTAIndependent statistical analysis of A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199): primary endpoint results, effect estimate with…
- SISIndependent statistical analysis of A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis): primary…
- SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF: Complete Statistical AnalysisIndependent statistical analysis of SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SISCAIndependent statistical analysis of Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SISTA-PIndependent statistical analysis of Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06307028).
- SISTErIndependent statistical analysis of Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00064662).
- SISTERSIndependent statistical analysis of SISTERS: Spasticity In Stroke Study - Randomized Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01032239).
- Sitagliptin Added-on to Insulin Study (0431-051): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Added-on to Insulin Study (0431-051): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00395343).
- Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00449930).
- Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sitagliptin in Combination With Metformin and Sulfonylurea: Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin in Combination With Metformin and Sulfonylurea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00686634).
- Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant: Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01186562).
- Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01065766).
- Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS): Complete Statistical AnalysisIndependent statistical analysis of Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- site markingIndependent statistical analysis of Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation Solutions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas: Complete Statistical AnalysisIndependent statistical analysis of Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02978859).
- Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety: Complete Statistical AnalysisIndependent statistical analysis of Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SiyakhanaIndependent statistical analysis of Community Health Worker Training to Reduce Depression and Substance Use Stigma in TB/HIV Care in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women: Complete Statistical AnalysisIndependent statistical analysis of SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients: Complete Statistical AnalysisIndependent statistical analysis of SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness: Complete Statistical AnalysisIndependent statistical analysis of Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Skin Surface and Intradermal Temperature Responses to Heat Stress: Complete Statistical AnalysisIndependent statistical analysis of Skin Surface and Intradermal Temperature Responses to Heat Stress: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06593067).
- SKYGGNIndependent statistical analysis of OCS-01 in Treating Inflammation and Pain in Post-cataract Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130802).
- Skylight 2Independent statistical analysis of A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2: primary endpoint results, effect estimate with confidence…
- SKYLINEIndependent statistical analysis of Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SKYSCRAPER-06Independent statistical analysis of SKYSCRAPER-06, evaluating tiragolumab plus atezolizumab and chemotherapy versus pembrolizumab plus chemotherapy in previously untreated advanced non-squamous NSCLC, with detailed interpretation of PFS, OS, response, quality-of-life, and safety analyses.
- SLAMIndependent statistical analysis of Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SLAM-PDIndependent statistical analysis of Speech, Linguistic and Acoustic Markers in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04273672).
- SLD3Independent statistical analysis of Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SLEIndependent statistical analysis of A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689350).
- Sleep and Circadian Treatments for Shift Workers: Complete Statistical AnalysisIndependent statistical analysis of Sleep and Circadian Treatments for Shift Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03813654).
- Sleep Apnea Treatment After Stroke (SATS): Complete Statistical AnalysisIndependent statistical analysis of Sleep Apnea Treatment After Stroke (SATS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00282815).
- Sleep Device Testing to Promote Sleep in Infants: Complete Statistical AnalysisIndependent statistical analysis of Sleep Device Testing to Promote Sleep in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05078112).
- Sleep GLP-1Independent statistical analysis of The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Sleep in Pediatric HSCT: Complete Statistical AnalysisIndependent statistical analysis of Sleep in Pediatric HSCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04106089).
- Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management Intervention: Complete Statistical AnalysisIndependent statistical analysis of Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sleep Schedules Modifications in Sleep Apnea Patients Treated by nCPAP: Complete Statistical AnalysisIndependent statistical analysis of Sleep Schedules Modifications in Sleep Apnea Patients Treated by nCPAP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01355419).
- Sleep Treatment for Teens: Complete Statistical AnalysisIndependent statistical analysis of Sleep Treatment for Teens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05397353).
- Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea: Complete Statistical AnalysisIndependent statistical analysis of Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SleepTightIndependent statistical analysis of Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SLICKIndependent statistical analysis of Spectacles Lens in Concussed Kids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03123822).
- SLIMM-T2DIndependent statistical analysis of Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SLSIndependent statistical analysis of Scleroderma Lung Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00004563).
- SLSIIIIndependent statistical analysis of Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03221257).
- SLUMBERIndependent statistical analysis of Improving Sleep Using Mentored Behavioral and Environmental Restructuring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03327324).
- SLVP023Independent statistical analysis of Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SMA-TBIndependent statistical analysis of Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04575519).